Intraocular pressure effects of pegaptanib (macugen) injections in patients with and without glaucoma

Am J Ophthalmol. 2008 Jan;145(1):185; author reply 186. doi: 10.1016/j.ajo.2007.08.037.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Aptamers, Nucleotide / therapeutic use*
  • Chronic Disease
  • Glaucoma, Open-Angle / drug therapy*
  • Humans
  • Injections
  • Intraocular Pressure / drug effects*
  • Macular Degeneration / drug therapy
  • Tonometry, Ocular
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*
  • Vitreous Body

Substances

  • Angiogenesis Inhibitors
  • Aptamers, Nucleotide
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • pegaptanib